Last updated on April 2018

Trident II Tritanium Acetabular Shell Outcomes Study


Brief description of study

The purpose of this study is to review the performance and success rate of an FDA approved cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much this happens in patients who have hip replacement with similar cementless acetabular shells.

Clinical Study Identifier: NCT02999009

Contact Investigators or Research Sites near you

Start Over

Alana Levine, MS

St. Joseph Mercy Hospital Health System
Ypsilanti, MI United States
  Connect »

Russell Cohen, MD

Tucson Orthopaedic Institute
Tucson, AZ United States
  Connect »

Geoffrey Westrich, MD

Hopsital for Special Surgery
New York, NY United States
  Connect »

Daniel Del Gaizo, MD

UNC Orthopaedics
Chapel Hill, NC United States
  Connect »

Benjamin Domb, MD

Hinsdale Orthopaedics
Westmont, IL United States
  Connect »

Fabio Orozco, MD

Rothman Institute
Egg Harbor Township, NJ United States
  Connect »